McKesson Subpoenaed By N.Y. Attorney General
This article was originally published in The Pink Sheet Daily
McKesson has received a subpoena from the New York Attorney General seeking information related to the "secondary" pharmaceutical wholesale market, the company said in an April 8 filing with the Securities & Exchange Commission
You may also be interested in...
Pharmaceutical wholesalers including Cardinal, ABC are subpoenaed by AG Eliot Spitzer's office in an inquiry into the wholesale secondary market, which has been associated with counterfeiting. The three top wholesalers have previously stated their intentions to cut back on secondary purchases.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.